Diabetes Mellitus, Type 2

• Baker Heart Research Institute — Melbourne, Victoria, Australia

• University of Michigan, Department of Family Medicine — Ann Arbor, Michigan, United States

• University of Arkansas for Medical Sciences — Little Rock, Arkansas, United States

• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — Keswick, South Australia, Australia
• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — Fitzroy, Victoria, Australia
• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — Fremantle, Western Australia, Australia
• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — London, Ontario, Canada

• Sanofi-Aventis Administrative Office — Milan, Italy

Not specified

• Sanofi-Aventis — Berlin, Germany

• Sanofi-Aventis Administrative Office — Milan, Italy

• Sanofi-Aventis Administrative Office — Bromma, Sweden

• Tehran University Of Medical Sciences — Tehran, Tehran Province, Iran